HCG Novarel is an injectable prescription drug used to used to treat hypogonadism in men and induce ovulation by stimulating the release of the egg from the follicle in women. In men, stimulates Leydig (interstitial) cells of the testes to produce androgens (testosterone). In women, behaves like luteinizing hormone (LH) to assist the corpus luteum in releasing progesterone, which is crucial to preparation of uterine lining for implantation. HCG Novarel should be used under the close supervision of a physician as the side effects can be severe, especially when HCG Novarel is used as a fertility treatment.
NOTE: HCG NOVAREL HAS NO KNOWN EFFECT ON FAT MOBILIZATION, APPETITE OR SENSE OF HUNGER, OR BODY FAT DISTRIBUTION. HCG HAS NOT BEEN DEMONSTRATED TO BE EFFECTIVE ADJUNCTIVE THERAPY IN THE TREATMENT OF OBESITY. THERE IS NO SUBSTANTIAL EVIDENCE THAT IT INCREASES WEIGHT LOSS BEYOND THAT RESULTING FROM CALORIC RESTRICTION, THAT IT CAUSES A MORE ATTRACTIVE OR "NORMAL" DISTRIBUTION OF FAT, OR THAT IT DECREASES THE HUNGER AND DISCOMFORT ASSOCIATED WITH CALORIE-RESTRICTED DIETS.
Drug Information
MEN'S HEALTH
Viagra
Propecia
WOMEN'S HEALTH
Diflucan
Vaniqa
ALLERGIES
Allegra
Claritin
HORMONE THERAPY
HCG Novarel
Saizen
SEXUAL HEALTH
Famvir
Valtrex
Zovirax
SKIN CARE
Nizoral
Renova
Retin-A
ARTHRITIS
Celebrex
STOP SMOKING
Zyban
ANTIBIOTICS
Azithromycin
Two-Vial Package
Withdraw sterile air from lyophilized vial and inject into diluent vial. Remove 10 mL from diluent vial and add to lyophilized vial; agitate gently until solution is complete.
Intramuscular Use Only
The dosage regimen employed in any particular case will depend upon the indication for use, the age and weight of the patient and the physician's preference. The following regimens have been advocated by various authorities.
1. 4,000 USP Units three times weekly for three weeks.
2. 5,000 USP Units every second day for four injections.
3. 15 injections of 500 to 1,000 USP Units over a period of six weeks.
4. 500 USP Units three times weekly for four to six weeks. If this course of treatment is not successful, another is begun one month later giving 1,000 USP Units per injection.
1. 500 to 1,000 USP Units three times a week for three weeks, followed by the same dose twice a week for three weeks.
2. 4,000 USP Units three times weekly for six to nine months, following which the dosage may be reduced to 2,000 USP Units three times weekly for an additional three months.
Induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure and who has been appropriately pretreated with human menotropins (see prescribing information for menotropins for dosage and administration for that drug product). 5,000 to 10,000 USP Units one day following the last dose of menotropins. (A dosage of 10,000 Units is recommended in the labeling for menotropins.)
IMPORTANT: USE COMPLETELY WITHIN 60 DAYS AFTER RECONSTITUTION. REFRIGERATE AFTER RECONSTITUTION.
HCG Novarel should be used in conjunction with human menopausal gonadotropins only by physicians experienced with infertility problems who are familiar with the criteria for patient selection, contraindications, warnings, precautions and adverse reactions described in the package insert for menotropins. The principal serious adverse reactions are:
Other side effects of HCG Novarel include: headache, irritability, restlessness, depression, fatigue, edema, precocious puberty, gynecomastia and pain at the site of injection.